Diazepam
Diastat, Diazepam, Libervant, Valium, Valtoco (diazepam) is a small molecule pharmaceutical. Diazepam was first approved as Valium on 1982-01-01. It is used to treat alcohol withdrawal delirium, muscle spasticity, panic disorder, and status epilepticus in the USA. The pharmaceutical is active against gamma-aminobutyric acid receptor subunit alpha-1, gamma-aminobutyric acid receptor subunit alpha-3, and gamma-aminobutyric acid receptor subunit alpha-2. In addition, it is known to target thyrotropin-releasing hormone receptor.
Download report
Favorite
Events Timeline
Commercial
Clinical
Drug
Target
Variants
Financial
Trends
Safety
Events Timeline
5D
1M
3M
6M
YTD
1Y
2Y
5Y
Max
Events
FDA approval date
EMA approval date
Patent expiration date
Study first post date
Last update post date
Start date
Primary completion date
Completion date
Results first post date
Mock data
Subscribe for the real data
Subscribe for the real data
Commercial
Trade Name
FDA
EMA
Diastat acudial, Diazepam, Libervant, Valium, Valtoco (discontinued: Diastat acudial, Diazepam, Dizac, Valium, Valrelease)
Drug Products
FDA
EMA
New Drug Application (NDA)
New Drug Application (NDA)
Abbreviated New Drug Application (ANDA)
Abbreviated New Drug Application (ANDA)
Diazepam
Tradename | Company | Number | Date | Products |
|---|---|---|---|---|
| LIBERVANT | Aquestive Therapeutics | N-218623 RX | 2024-04-26 | 5 products, RLD, RS |
| DIASTAT | Bausch Health Companies | N-020648 RX | 1997-07-29 | 1 products, RLD, RS |
| DIASTAT ACUDIAL | Bausch Health Companies | N-020648 RX | 2005-09-15 | 2 products, RLD, RS |
| VALTOCO | Neurelis | N-211635 RX | 2020-01-10 | 3 products, RLD, RS |
| VALIUM | Waylis Therapeutics | N-013263 RX | 1982-01-01 | 3 products, RLD, RS |
Show 5 discontinued
Labels
FDA
EMA
Brand Name | Status | Last Update |
|---|---|---|
| diazepam | ANDA | 2024-10-22 |
| diazepam diazepam intensol | ANDA | 2016-07-05 |
| diazepam intensol | ANDA | 2022-11-16 |
| gabavale-5 | unapproved drug other | 2011-08-01 |
| libervant | New Drug Application | 2024-04-27 |
| valium | New Drug Application | 2023-11-28 |
| valtoco | New Drug Application | 2023-08-15 |
Indications
FDA
EMA
Agency Specific
FDA
EMA
Expiration | Code | ||
|---|---|---|---|
DIAZEPAM, VALTOCO, NEURELIS INC | |||
| 2027-01-10 | ODE-279 | ||
| 2023-01-10 | NP | ||
HCPCS
Code | Description |
|---|---|
| J3360 | Injection, diazepam, up to 5 mg |
Clinical
Clinical Trials
187 clinical trials
View more details
Mock data
Subscribe for the real data
Subscribe for the real data
Indications Phases 4
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
|---|---|---|---|---|---|---|---|---|---|
| Epilepsy | D004827 | EFO_0000474 | G40.9 | 5 | 8 | 3 | 2 | 2 | 17 |
| Seizures | D012640 | HP_0002069 | G40.4 | 2 | 2 | 2 | 3 | 4 | 13 |
| Pain | D010146 | EFO_0003843 | R52 | — | 5 | 1 | 3 | 1 | 9 |
| Postoperative pain | D010149 | — | G89.18 | — | 2 | — | 1 | 4 | 7 |
| Substance withdrawal syndrome | D013375 | EFO_0005800 | — | — | — | 1 | 1 | 5 | 7 |
| Syndrome | D013577 | — | — | — | 1 | 2 | 1 | 3 | 6 |
| Alcohol withdrawal delirium | D000430 | EFO_1000800 | — | — | — | — | 2 | 3 | 5 |
| Non-small-cell lung carcinoma | D002289 | — | — | 1 | 1 | 1 | 1 | — | 4 |
| Alcoholism | D000437 | EFO_0003829 | F10.1 | — | — | — | 1 | 3 | 4 |
| Substance-related disorders | D019966 | EFO_0003890 | F13 | — | — | — | 1 | 2 | 3 |
Show 28 more
Indications Phases 3
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
|---|---|---|---|---|---|---|---|---|---|
| Squamous cell carcinoma of head and neck | D000077195 | — | — | — | 2 | 4 | — | 1 | 7 |
| Breast neoplasms | D001943 | EFO_0003869 | C50 | 1 | — | 4 | — | 1 | 6 |
| Hiv infections | D015658 | EFO_0000764 | B20 | — | — | 5 | — | — | 5 |
| Head and neck neoplasms | D006258 | — | — | 1 | 1 | 2 | — | 1 | 5 |
| Status epilepticus | D013226 | EFO_0008526 | G41 | — | 2 | 3 | — | 2 | 5 |
| Anxiety disorders | D001008 | EFO_0006788 | F41.1 | 1 | — | 2 | — | 1 | 4 |
| Squamous cell carcinoma | D002294 | — | — | — | 2 | 1 | — | 1 | 4 |
| Leukemia | D007938 | — | C95 | 2 | — | 1 | — | — | 3 |
| Lung neoplasms | D008175 | HP_0100526 | C34.90 | 1 | — | 1 | — | 1 | 3 |
| Low back pain | D017116 | HP_0003419 | M54.5 | — | 1 | 1 | — | 2 | 3 |
Show 35 more
Indications Phases 2
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
|---|---|---|---|---|---|---|---|---|---|
| Pancreatitis | D010195 | HP_0001733 | K85 | — | 1 | — | — | 4 | 5 |
| Chronic pancreatitis | D050500 | EFO_0000342 | K86.1 | — | 1 | — | — | 4 | 5 |
| Sarcoma | D012509 | — | — | 2 | 1 | — | — | — | 3 |
| Glioblastoma | D005909 | EFO_0000515 | — | 1 | 1 | — | — | — | 2 |
| Drug resistant epilepsy | D000069279 | — | — | — | 1 | — | — | 1 | 2 |
| Abdominal pain | D015746 | HP_0002027 | R10.9 | — | 1 | — | — | 1 | 2 |
| Carcinoma | D002277 | — | C80.0 | — | 1 | — | — | 1 | 2 |
| Fibrosis | D005355 | — | — | 1 | 1 | — | — | — | 2 |
| Idiopathic pulmonary fibrosis | D054990 | — | J84.112 | 1 | 1 | — | — | — | 2 |
| Pulmonary fibrosis | D011658 | — | — | 1 | 1 | — | — | — | 2 |
Show 26 more
Indications Phases 1
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
|---|---|---|---|---|---|---|---|---|---|
| Healthy volunteers/patients | — | — | — | 4 | — | — | — | 4 | 8 |
| Neoplasms | D009369 | — | C80 | 1 | — | — | — | 2 | 3 |
| Delirium | D003693 | — | R41.0 | 1 | — | — | — | 1 | 2 |
| Emergence delirium | D000071257 | — | — | 1 | — | — | — | 1 | 2 |
| Myelodysplastic syndromes | D009190 | — | D46 | 1 | — | — | — | — | 1 |
| Myeloid leukemia acute | D015470 | — | C92.0 | 1 | — | — | — | — | 1 |
| Hematologic neoplasms | D019337 | — | — | 1 | — | — | — | — | 1 |
| Renal cell carcinoma | D002292 | EFO_0000376 | — | 1 | — | — | — | — | 1 |
| Thyroid neoplasms | D013964 | EFO_0003841 | — | 1 | — | — | — | — | 1 |
| Non-hodgkin lymphoma | D008228 | — | C85.9 | 1 | — | — | — | — | 1 |
Show 13 more
Indications Without Phase
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
|---|---|---|---|---|---|---|---|---|---|
| Labor pain | D048949 | — | — | — | — | — | — | 4 | 4 |
| Arthritis | D001168 | HP_0001369 | M05-M14 | — | — | — | — | 2 | 2 |
| Pancreatic neoplasms | D010190 | EFO_0003860 | C25 | — | — | — | — | 2 | 2 |
| Recurrence | D012008 | — | — | — | — | — | — | 2 | 2 |
| Drug interactions | D004347 | — | — | — | — | — | — | 1 | 1 |
| Knee osteoarthritis | D020370 | EFO_0004616 | M17 | — | — | — | — | 1 | 1 |
| Rheumatoid arthritis | D001172 | EFO_0000685 | M06.9 | — | — | — | — | 1 | 1 |
| Analgesia | D000698 | — | — | — | — | — | — | 1 | 1 |
| Aortic dissection | D000784 | — | I71.0 | — | — | — | — | 1 | 1 |
| Video-assisted thoracic surgery | D020775 | — | — | — | — | — | — | 1 | 1 |
Show 47 more
Epidemiology
Epidemiological information for investigational and approved indications
View more details
Drug
General
| Drug common name | Diazepam |
| INN | diazepam |
| Description | Diazepam is a 1,4-benzodiazepinone that is 1,3-dihydro-2H-1,4-benzodiazepin-2-one substituted by a chloro group at position 7, a methyl group at position 1 and a phenyl group at position 5. It has a role as a xenobiotic, an environmental contaminant, an anxiolytic drug, an anticonvulsant and a sedative. It is a 1,4-benzodiazepinone and an organochlorine compound. |
| Classification | Small molecule |
| Drug class | antianxiety agents (diazepam type) |
| Image (chem structure or protein) |  |
| Structure (InChI/SMILES or Protein Sequence) | CN1C(=O)CN=C(c2ccccc2)c2cc(Cl)ccc21 |
Identifiers
| PDB | — |
| CAS-ID | 439-14-5 |
| RxCUI | — |
| ChEMBL ID | CHEMBL12 |
| ChEBI ID | 49575 |
| PubChem CID | 3016 |
| DrugBank | DB00829 |
| UNII ID | Q3JTX2Q7TU (ChemIDplus, GSRS) |
Target
Agency Approved
No data
Alternate
ADRA1A
ADRA1A
ALB
ALB
Organism
Homo sapiens
Gene name
ADRA1A
Gene synonyms
ADRA1C
NCBI Gene ID
Protein name
alpha-1A adrenergic receptor
Protein synonyms
Alpha-1A adrenoceptor, Alpha-1A adrenoreceptor, Alpha-1C adrenergic receptor, Alpha-adrenergic receptor 1c, G protein coupled receptor
Uniprot ID
Mouse ortholog
Adra1a (11549)
alpha-1A adrenergic receptor (Q8BV77)
Variants
No data
Financial
Revenue by drug
$
€
£
â‚£
No data
Estimated US medical usage
Diazepam
Total medical expenditures per year (USD, in millions)
Mock data
Subscribe for the real data
Subscribe for the real data
Number of persons purchased
Mock data
Subscribe for the real data
Subscribe for the real data
Number of purchases
Mock data
Subscribe for the real data
Subscribe for the real data
Refill frequency
Mock data
Subscribe for the real data
Subscribe for the real data
Price per prescription (USD)
Mock data
Subscribe for the real data
Subscribe for the real data
Tabular view
Trends
PubMed Central
Top Terms for Disease or Syndrome:
Mock data
Subscribe for the real data
Subscribe for the real data
Additional graphs summarizing 1,275,594 documents
View more details
Safety
Black-box Warning
Black-box warning for: Diazepam, Diazepam intensol, Libervant, Valium, Valtoco
Adverse Events
Top Adverse Reactions
Mock data
Subscribe for the real data
Subscribe for the real data
47,621 adverse events reported
View more details
© 2020-2024 Collaborative Drug Discovery Inc. (CDD) | Terms of Use